UNLIMITED TURBO BULL - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Euronext Paris 12:30:00 2024-05-28 EDT | ||
| 0.905 EUR | -6.22% |
|
| Current month | -14.62% | ||
| 1 month | -9.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 0.905 | -6.22% |
| 24-05-27 | 0.965 | +4.32% |
| 24-05-24 | 0.925 | -5.13% |
| 24-05-23 | 0.975 | -2.01% |
| 24-05-22 | 0.995 | +1.02% |
Real-time Euronext Paris
Last update May 28, 2024 at 12:30 pm
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
Société Générale
|
| 5G71S | |
| ISIN | DE000SW8YDG5 |
| Date issued | 2024-04-12 |
| Strike | 39.13 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.97 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.395 € |
|---|---|
| Lowest since issue | 0.885 € |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.1
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.61%
- Stock Market
- Certificates
- 5G71S Certificat
